William D. Clark, Senior VP, Chief Business Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 3,200 shares at $29.63 ($94K) on 2007-02-01, disclosed to the SEC on 2007-02-01.
Scheduled sale ($94k) by Senior VP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.42 | 599 | $18K | 18.7% |
| 2 | $29.43 | 100 | $3K | 3.1% |
| 3 | $29.44 | 100 | $3K | 3.1% |
| 4 | $29.48 | 100 | $3K | 3.1% |
| 5 | $29.50 | 901 | $27K | 28.1% |
| 6 | $29.50 | 200 |
| $6K |
| 6.2% |
| 7 | $29.52 | 500 | $15K | 15.6% |
| 8 | $29.54 | 100 | $3K | 3.1% |
| 9 | $29.56 | 100 | $3K | 3.1% |
| 10 | $29.63 | 100 | $3K | 3.1% |
| 11 | $29.65 | 100 | $3K | 3.1% |
| 12 | $29.67 | 100 | $3K | 3.1% |
| 13 | $29.68 | 100 | $3K | 3.1% |
| 14 | $29.80 | 100 | $3K | 3.2% |
| Total | $29.52 avg | 3,200 | $94K | 100% |
| Filing → |
| GNCA | SELL | 2022-06-02 | $7K | — | Filing → |
| GNCA | SELL | 2022-04-05 | $5K | — | Filing → |
| GNCA | SELL | 2022-03-17 | $13K | — | Filing → |